17 alpha-hydroxyprogesterone caproate has been researched along with Labor, Premature in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (15.22) | 18.7374 |
1990's | 1 (2.17) | 18.2507 |
2000's | 18 (39.13) | 29.6817 |
2010's | 18 (39.13) | 24.3611 |
2020's | 2 (4.35) | 2.80 |
Authors | Studies |
---|---|
Alizadeh, F; Mahmoudinia, M; Mirteimoori, M; Niroumand, S; Pourali, L | 1 |
Biron-Shental, T; Cohen, G; Miller, N; Moran, R; Ovadia, M; Schreiber, H; Shavit, M; Shechter-Maor, G; Weitzner, O; Yagur, Y | 1 |
Kawasaki, Y; Kitajima, I; Makimoto, M; Niimi, H; Saito, S; Shiozaki, A; Tamura, K; Ueno, T; Yoneda, N; Yoneda, S; Yoshida, T; Yoshino, O | 1 |
Cahill, AG; Carter, EB; Macones, GA; Olsen, MA; Stout, MJ; Tuuli, MG | 1 |
Fan-Havard, P; Franco, A; Prescott, GM; Schmouder, VM | 1 |
Bekedam, DJ; Bloemenkamp, KW; Bruinse, HW; Christiaens, GC; Kwee, A; Lim, AC; Mol, BW; Mulder, EJ; Versteegh, EM | 1 |
Briery, CM; Chauhan, SP; Klauser, CK; Magann, EF; Martin, RW; Morrison, JC | 1 |
Caritis, S; Feghali, M; Venkataramanan, R | 1 |
Abdul Karim, AK; Lim, PS; Ng, BK; Ng, KS; Omar, MH; Shafiee, MN | 1 |
Hibbard, JU; Leftwich, H; Stetson, B; Wilkins, I | 1 |
Bayesh, S; Esmailzadeh, A; Heidari, R; Pirjani, R; Rahimi-Foroushani, A | 1 |
Dante, G; Facchinetti, F; Paganelli, S; Venturini, P; Volpe, A | 1 |
Keeler, SM; Kiefer, D; Novetsky, AP; Quinones, JN; Rochon, M; Rust, O | 1 |
Facchinetti, F; Vaccaro, V | 1 |
Fox, NS; Istwan, NB; Klauser, CK; Rebarber, A; Rhea, DJ; Saltzman, DH; Stanziano, GJ | 1 |
Chawanpaiboon, S; Pimol, K; Sirisomboon, R | 1 |
Armstrong, J | 1 |
Khadem, N; Mohajeri, T; Saghafi, N; Shakeri, MT | 1 |
King, AS; Omar, SZ; Tan, PC; Vallikkannu, N | 1 |
Gupta, S; Roman, AS | 1 |
Debieve, F; Hubinont, C | 1 |
Bandino, JP; Hivnor, CM; Kennedy, JS; Thoppil, J | 1 |
Azimi, S; Azria, E; Bohec, C; Capelle, M; Chauveaud, A; Connan, L; Deruelle, P; Desbrière, R; Langer, B; Mantel, A; Perrotin, F; Porcher, R; Rozenberg, P; Vayssière, C; Winer, N | 1 |
Caritis, SN; Carpenter, M; Conway, D; Dombrowski, MP; Gabbe, S; Hauth, JC; Iams, JD; Klebanoff, M; Leveno, KJ; Meis, PJ; Mercer, B; Miodovnik, M; Moawad, AH; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Sibai, B; Spong, CY; Thom, E; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
Greene, MF | 1 |
Brancazio, LR; Heine, RP; Murtha, AP | 1 |
EICHNER, E | 1 |
Doggrell, SA | 1 |
Secher, NJ; Skajaa, K | 1 |
Caritis, SN; Carpenter, M; Conway, D; Dombrowski, MP; Gabbe, S; Iams, JD; Klebanoff, M; Leindecker, S; Leveno, KJ; Meis, PJ; Mercer, B; Miodovnik, M; Moawad, AH; Northen, A; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Sibai, BM; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
Macones, GA; Odibo, AO; Polsky, D; Stamilio, DM | 1 |
Bloemenkamp, KW; Boer, K; Bruinse, HW; Duvekot, JJ; Erwich, JJ; Hasaart, TH; Hummel, P; Lim, AC; Mol, BW; Offermans, JP; Santema, JG; Scheepers, HC; Schöls, WA; van Oirschot, CM; Vandenbussche, FP; Wouters, MG | 1 |
Thornton, JG | 1 |
Klebanoff, MA | 1 |
Barton, JR; How, HY; Istwan, NB; Rhea, DJ; Stanziano, GJ | 1 |
Ahmed, MS; Fokina, V; Hankins, GD; Nanovskaya, TN; Yan, R | 1 |
Cleary-Goldman, J; Desch, C; Istwan, NB; Rebarber, A; Rhea, DJ; Russo-Stieglitz, K; Saltzman, DH | 1 |
Caritis, SN; Carpenter, M; Conway, D; Dombrowski, MP; Iams, JD; Klebanoff, MA; Leveno, KJ; Meis, PJ; Mercer, BM; Miodovnik, M; Moawad, AH; Northen, A; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Sibai, BM; Thorp, JM; Varner, MW; Wapner, RJ; Zhao, Y | 1 |
Behrman, SJ | 1 |
Brekken, AL; Gilstrap, LC; Hauth, JC; Hauth, JM | 1 |
Creasy, RK; Herron, MA | 1 |
Hartikainen-Sorri, AL; Jänne, O; Järvinen, PA; Kauppila, A; Tuimala, R | 1 |
Hartikainen-Sorri, AL; Kauppila, A; Tuimala, R | 1 |
Keirse, MJ | 1 |
Suvonnakote, T | 1 |
8 review(s) available for 17 alpha-hydroxyprogesterone caproate and Labor, Premature
Article | Year |
---|---|
The rebirth of progesterone in the prevention of preterm labor.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progesterone; Randomized Controlled Trials as Topic | 2013 |
Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progestins | 2014 |
Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Habitual; Anti-Inflammatory Agents; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Maintenance; Pregnancy Outcome; Progesterone; Progesterone Congeners; Prostaglandins; Randomized Controlled Trials as Topic | 2009 |
Prevention of preterm labour: 2011 update on tocolysis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adrenergic beta-Agonists; Anti-Bacterial Agents; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Hydroxyprogesterones; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Progesterone; Receptors, Oxytocin; Tocolysis; Tocolytic Agents | 2011 |
Recurrent hope for the treatment of preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Habitual; Anti-Bacterial Agents; Clinical Trials as Topic; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Risk Factors; Treatment Outcome | 2003 |
Subgroup analysis in obstetrics clinical trials.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Anti-Bacterial Agents; Black or African American; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Probability; Randomized Controlled Trials as Topic; Research Design; Vaginosis, Bacterial; White People | 2007 |
Prevention of preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Bed Rest; Cervix Uteri; Coitus; Female; Humans; Hydroxyprogesterones; Infections; Nutritional Physiological Phenomena; Obstetric Labor, Premature; Patient Education as Topic; Pregnancy; Progesterone; Risk; Socioeconomic Factors | 1981 |
Progestogen administration in pregnancy may prevent preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Threatened; Female; Humans; Hydroxyprogesterones; Meta-Analysis as Topic; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic | 1990 |
16 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Labor, Premature
Article | Year |
---|---|
Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Dydrogesterone; Female; Humans; Injections, Intramuscular; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Progestins; Treatment Outcome | 2022 |
The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Apgar Score; Birth Weight; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolysis | 2014 |
17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Cervical Length Measurement; Cervix Uteri; Female; Gestational Age; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Premature Birth; Progesterone; Prospective Studies; Suppositories; Treatment Outcome; Ultrasonography; Young Adult | 2017 |
17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cervical Ripening; Cervix Uteri; Colorimetry; Cytokines; Female; Humans; Hydroxyprogesterones; Interleukin-1beta; Interleukin-6; Interleukin-8; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Prospective Studies; Tumor Necrosis Factor-alpha | 2008 |
A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerclage, Cervical; Cervical Length Measurement; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Injections, Intramuscular; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Risk Factors; Uterine Cervical Incompetence; Young Adult | 2009 |
Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Bed Rest; Delayed-Action Preparations; Female; Humans; Hydroxyprogesterones; Middle Aged; Nifedipine; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Time Factors; Tocolytic Agents; Uterine Contraction; Young Adult | 2011 |
Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Treatment Outcome | 2011 |
Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adrenal Cortex Hormones; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Progestins; Tocolytic Agents; Treatment Outcome; Young Adult | 2012 |
Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolysis; Tocolytic Agents; Treatment Outcome | 2012 |
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Birth Weight; Cerebral Hemorrhage; Double-Blind Method; Enterocolitis, Necrotizing; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Obstetric Labor, Premature; Oxygen Inhalation Therapy; Pregnancy; Pregnancy Outcome; Progesterone Congeners; Risk; Survival Analysis | 2003 |
Recurrent hope for the treatment of preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Habitual; Anti-Bacterial Agents; Clinical Trials as Topic; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Risk Factors; Treatment Outcome | 2003 |
Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Pregnancy, Multiple; Progestins; Treatment Outcome | 2007 |
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Estriol; Female; Gestational Age; Humans; Hydroxyprogesterones; Longitudinal Studies; Obstetric Labor, Premature; Placental Circulation; Pregnancy; Progesterone; Saliva | 2008 |
The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Double-Blind Method; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Military Medicine; Obstetric Labor, Premature; Outcome and Process Assessment, Health Care; Pregnancy; Prospective Studies; Random Allocation | 1983 |
Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Double-Blind Method; Estrogens; Female; Hydroxyprogesterones; Obstetric Labor, Premature; Placental Lactogen; Pregnancy; Pregnancy Trimester, Third; Pregnancy, Multiple; Progesterone; Testosterone; Twins | 1980 |
Progestogen administration in pregnancy may prevent preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Threatened; Female; Humans; Hydroxyprogesterones; Meta-Analysis as Topic; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic | 1990 |
24 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Labor, Premature
Article | Year |
---|---|
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies | 2022 |
17OHP-C in patients with spontaneous preterm labor and intact membranes: is there an effect according to the presence of intra-amniotic inflammation?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Amnion; Amniotic Fluid; Cohort Studies; Estrogen Antagonists; Female; Gestational Age; Humans; Inflammation; Interleukin-8; Obstetric Labor, Premature; Pregnancy; Retrospective Studies; Young Adult | 2018 |
Practical considerations with 17-Hydroxyprogesterone caproate for preterm birth prevention: does timing of initiation and compliance matter?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Drug Administration Schedule; Estrogen Antagonists; Female; Gestational Age; Humans; Medication Adherence; Middle Aged; Obstetric Labor, Premature; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Recurrence; Retrospective Studies; Young Adult | 2019 |
Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Biometry; Birth Weight; Body Size; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Obstetric Labor, Premature; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pregnancy, Twin; Progestins; Risk Factors; Sex Factors; Treatment Outcome; Twins | 2013 |
Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Progestins; Urogenital Abnormalities; Uterus | 2016 |
Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerclage, Cervical; Cohort Studies; Female; Humans; Hydroxyprogesterones; Indomethacin; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2016 |
Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Cohort Studies; Female; Home Care Services; Humans; Hydroxyprogesterones; Injections, Intramuscular; Obstetric Labor, Premature; Patient Education as Topic; Patient Satisfaction; Pregnancy; Premature Birth; Prenatal Care; Progestins; Young Adult | 2010 |
Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Drug Approval; Drug Compounding; Drug Costs; Female; Health Care Costs; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Patents as Topic; Pregnancy; Premature Birth; United States; United States Food and Drug Administration | 2011 |
17-α hydroxyprogesterone caproate for the prevention of preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prenatal Care; United States; United States Food and Drug Administration; Women's Health | 2012 |
Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Autoimmune Diseases; Dermatitis; Female; Fluorescent Antibody Technique, Indirect; Humans; Hydroxyprogesterones; Iatrogenic Disease; Obstetric Labor, Premature; Pregnancy; Progesterone; Progestins | 2011 |
Progesterone and preterm delivery--deja vu all over again.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Risk | 2003 |
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Castor Oil; Female; Humans; Hydroxyprogesterones; Injections; Labor, Induced; Obstetric Labor, Premature; Pregnancy | 2003 |
Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Female; Fetus; Humans; Hydroxyprogesterones; Labor, Obstetric; Obstetric Labor, Premature; Pregnancy; Progesterone | 1958 |
ACOG Committee Opinion. Use of progesterone to reduce preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy | 2003 |
[Can progesterone prevent premature birth?].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy | 2004 |
Does progesterone treatment influence risk factors for recurrent preterm delivery?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Humans; Hydroxyprogesterones; Multivariate Analysis; Obstetric Labor, Premature; Pregnancy; Progestins; Recurrence; Risk Factors | 2005 |
17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cost-Benefit Analysis; Decision Support Techniques; Female; Gestational Age; Health Care Costs; Hospitalization; Humans; Hydroxyprogesterones; Multivariate Analysis; Obstetric Labor Complications; Obstetric Labor, Premature; Parity; Pregnancy; Premature Birth; Progestins; Risk Factors; Secondary Prevention; United States | 2006 |
Progesterone and preterm labor--still no definite answers.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Intravaginal; Cervix Uteri; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Premature Birth; Progesterone; Twins | 2007 |
Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adolescent; Adult; Female; Gestational Age; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Premature Birth; Recurrence; Retrospective Studies; Tocolytic Agents; Treatment Outcome | 2007 |
The effect of esterases on 17alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Chromatography, High Pressure Liquid; Esterases; Female; Gestational Age; Humans; Hydroxyprogesterones; In Vitro Techniques; Liver; Obstetric Labor, Premature; Placenta; Pregnancy | 2008 |
The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerclage, Cervical; Cohort Studies; Estrogen Antagonists; Female; Gestational Age; Humans; Hydroxyprogesterones; Nursing Care; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2008 |
On reducing prematurity: the hospital's role.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adrenergic beta-Agonists; Female; Hospital Departments; Humans; Hydroxyprogesterones; Indomethacin; Obstetric Labor, Premature; Obstetrics and Gynecology Department, Hospital; Patient Education as Topic; Pregnancy; Prospective Studies; Risk | 1982 |
Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Estradiol; Estriol; Estrogen Antagonists; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Progesterone; Propanolamines; Ritodrine; Testosterone | 1980 |
Prevention of pre-term labour with progesterone.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Obstetric Labor, Premature; Pregnancy; Risk | 1986 |